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The role of the histamine H3 receptor (H3R) in anxiety is controversial, due to limitations
in drug selectivity and limited validity of behavioral tests used in previous studies. In the
present report, we describe two experiments. In the first one, Wistar rats were treated
with an H3R agonist (methimepip), and exposed to an open-field. In the second one,
Balb/c mice were treated with H3R agonist (methimepip) or antagonist (JNJ-5207852), and
exposed to an open space 3D maze which is a modified version of the radial-arm maze.
C57BL/6J saline treated mice were included for comparisons. When exposed to an empty
open field, Wistar rats spent more time in the outer area and made very low number of
brief crossings in the central area. However, when an object occupied the central area,
rats crossed frequently into and spent a long time in the central area. Administration of a
range of different doses of methimepip (selective H3R agonist) reduced the entries into
the central area with a novel object, indicating enhanced avoidance response. In the 3D
maze, both Balb/c and C57BL/6J saline-treated mice crossed frequently onto the bridges
that radiate from the central platform but only C57BL/6Jmice crossed onto the arms which
extend the bridges. This suggests that Balb/c mice are more anxious than C57BL/6J mice.
Neither methimepip nor JNJ-5207852 (selective H3R antagonist/inverse agonist) induced
entry into the arms of the maze, indicative of lack of anxiolytic effects.
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INTRODUCTION
The biogenic amine histamine is an important neurotrans-
mitter and neuromodulator in the CNS that has been impli-
cated in a variety of biological functions including thermo- and
immunoregulation, food intake, hyperexcitability, pain trans-
mission, arousal, reward, memory and emotional responses.
The histamine H3 receptor (H3R) has been characterized as
a presynaptic auto- and hetero -receptor on histaminergic
and non-histaminergic neurons, respectively. It modulates his-
tamine synthesis and release through negative feedback (Arrang
et al., 1987; Giannoni et al., 2009). The basic organization
and functional disposition of the histaminergic system is highly
conserved in the vertebrate brain. In the mammalian brain
histamine is synthesized and stored in the cell somata and
axon varicosities in restricted populations of neurons that orig-
inate from the tuberomammillary nucleus (TMN) located in
the posterior hypothalamus. Histaminergic neurons projecting
from the ventral ascending pathway have strong innervation at
the hypothalamus, diagonal band, septum, and olfactory bulb
whilst the dorsal pathway has lower density fibers which inner-
vate the thalamus, hippocampus, amygdala, and rostral fore-
brain structures, many of which play a role in cognitive and
emotional behaviors (Haas et al., 2008). They also modulate
the release of other neurotransmitters, including acetylcholine,
norepinephrine, serotonin, and dopamine, implicated further in
emotion (Arrang et al., 1995; Blandina et al., 1996; Threlfell et al.,
2004; Haas et al., 2008; Giannoni et al., 2009). Preclinical studies
suggest a role of H3Rs in a variety of cognitive disorders including
attention deficit hyperactivity disorder, Alzheimer’s disease and
schizophrenia (see Esbenshade et al., 2008; Chazot, 2010; Leurs
et al., 2011). There is growing evidence for a role of H3Rs in
fear-avoidance (e.g., Baldi et al., 2005). However, a limited num-
ber of studies have investigated the role of H3Rs in anxiety, and
these have proved inconsistent and even contradictory (Imaizumi
and Onodera, 1993; Frisch et al., 1998; Pérez-García et al., 1999;
Bongers et al., 2004; Dere et al., 2004; Rizk et al., 2004; Acevedo
et al., 2006; Yokoyama et al., 2009). Both H3R agonists and antag-
onists were reported to produce anxiolysis, anxiogenesis or no
effects in the current unconditioned tests of anxiety (Imaizumi
and Onodera, 1993; Pérez-García et al., 1999; Rizk et al., 2004;
Yokoyama et al., 2009). This is likely due to the selectivity of the
compounds used in the older studies and/or limitations of the
behavioral tests used for anxiety which all provides an option
for escape/avoidance and, therefore, cannot distinguish between
Frontiers in Systems Neuroscience www.frontiersin.org July 2012 | Volume 6 | Article 54 | 1
SYSTEMS NEUROSCIENCE
Abuhamdah et al. H3 histamine agonist and antagonist on anxiety
fear-induced avoidance and fear-induced anxiety (discussed in
detail in Ennaceur, 2012).
It has been reported that rats and mice exposed to an open-
field avoid the central area and avoid the presence of an object
in this area (Hughes, 2007). It has been also reported that these
animals avoid the open arms of the plus-maze (Handley and
Mithani, 1984; Pellow et al., 1985) and the lit chamber of the light-
dark box (Malin, 1974; Morgan and Kamp, 1980; Crawley, 1981).
This avoidance behavior has been interpreted as an indicator of
anxiety (discussed in Ennaceur et al., 2009b) though one cannot
exclude the possibility that animals express a natural preference
for protected and/or unlit spaces (see Malin, 1974; Morgan and
Kamp, 1980; Buhot, 1989) and they may have no interest or moti-
vation to venture into unprotected and/or lit spaces. Animals may
also express fear from novelty and escape to or avoid from the
protected and/or unlit space. In this case too, there is no objective
evidence that demonstrate the interest or motivation of animals
to approach the source of potential threat.
In the present report, we examined the behavior ofWistarmale
rats in the presence or absence of an object in the open-field,
and we assessed whether this would be affected by methimepip,
a selective histamine H3R agonist (Kitbunnadaj et al., 2005). As
stated above, we believe that exposure for the first time to the
open-field provides measures of fear-induced avoidance and we
expect that methimepip would affect these measures. We also
examined the behavior of Balb/c mice which were exposed to a
3D-maze and treated with or methimepip or JNJ-5207852, the
latter, a selective histamine H3R antagonist (Barbier et al., 2004).
In this second experiment, we included a group of C57BL/6J mice
that were treated with saline for comparisons. The 3D maze is
a modified version of the radial-arm maze. It consists of 8 arms
attached to bridges that radiate from a central platform. Animals
need to cross a bridge to access an arm of the maze. In this test
apparatus C57BL/6J mice cross onto arms of the maze on first
exposure (low anxiety strain), while Balb/c mice cross only onto
the bridges (high anxiety strain), indicative of differential anxiety
responses (Ennaceur et al., 2006, 2008; Ennaceur, 2011). If treat-
ments in Balb/c mice induced crossing onto arms of the maze
as seen with the control C57BL/6J mice, this would indicate an
anxiolytic effect. This test has been validated previously with an
anxiolytic agent, diazepam (Ennaceur et al., 2008).
The first experiment used rats because previous experiments in
the open-field with and without object were conducted with these
animals and demonstrated that the tests providemeasures of fear-
induced avoidance rather than fear-induced anxiety (Ennaceur
et al., 2009a,b). When exposed for the first time to an open-field,
rats show natural preference for the walls and corners and avoid
the center of the field because there is nothing there to explore.
When an object is present in the center they do approach and
explore the object.
The second experiment used mice because these were pre-
viously assessed for anxiety in the 3D maze and differences in
anxiety between strains of mice in this test is well established
(Ennaceur et al., 2006, 2008). We have only experience with
Wistar rats in this test but not with other strains of rats. It was
not worthwhile testing mice in the open-field as in our view it
does not provide measures of anxiety.
EXPERIMENT 1—OPEN-FIELD WITH ANDWITHOUT OBJECT
MATERIALS AND METHODS
Animals
Forty ninemaleWistar rats (six groups) supplied by Charles River
Laboratories (Kent, UK) were used in the present study. The ani-
mal weight was 190–210 g at the time of the. The colony roomwas
held under a 12 h light/12 h dark cycle (light 0700–1900 h at 180
Lux) and at 23◦C ± 1◦C. In order to avoid unequal light expo-
sure, the upper shelf was occupied with plastic cages filled with
sawdust. Rats were housed four per cage. Individual rats could be
identified by their cage number and their color code created with
indelible pen marker on their tail. Rats were left to acclimatize for
2 weeks before the start of the experiment. All rats had ad libitum
access to food and water. During their stay in respective hous-
ing conditions, they were removed three times a week from their
cages for cleaning the cages and renewing their food and water
supply. Animal treatment and husbandry were in accordance with
approved use of animals in scientific procedures regulated by the
Animals (Scientific Procedures) Act 1986, UK.
Drug treatments
Two groups of male Wistar rats received physiological saline,
the other groups received a single injection of one dose of
methimepip (1 and 2.5mg/kg i.p.) 30min before exposure to the
open-field with and without an object (Table 1). Methimepip was
a kind gift obtained from Professor Rob Leurs (VU, Amsterdam,
The Netherlands). Selection of dose concentrations was based on
previous in vivo studies (e.g., Kitbunnadaj et al., 2005).
Apparatus and testing procedure
The apparatus consists of an open box (width 80 × length 80 ×
height 50 cm) made of gray PVC. The surface of the open-field
was divided into outer, inner, and central areas. Each area was
16 cm wide. The illumination on the floor of the box apparatus
was 186Lux. The objects (width 8 × length 8 × height 13 cm) to
be explored were identical triplicate and were alternated between
animals. They were made of white ceramic. Rats were released
from the outer area of the open-field with the head oriented
toward a wall. They were left to explore for 10min.
Tools and recording measures
All sessions were video recorded and the behavior of rats was
analyzed with an in-house computer program, EventLog. The
recording of the behavior of rats was based on entries into defined
areas of the apparatus. An entry was recorded whenever a rat
crosses with all four paws into an area. EventLog records in
Table 1 | Groups and number of animals per groups in each test
condition.
Saline Methimepip Methimepip
1mg/kg i.p. 2.5mg/kg i.p.
Open-field without object n = 10 n = 7 n = 7
Open-field with object n = 9 n = 8 n = 8
The drugs were administered i.p. 30min before the test.
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sequential order the start and end of each crossing into an area
of the open-field. It provides measures of latency, frequency, and
duration of entries.
Measurement and statistical analysis
All data are expressed as mean ± s.e.m. Differences among
group means values for each measurement were tested for sig-
nificance with Two-Way ANOVA followed up with Newman–
Keuls post-hoc comparisons (Statistica for Windows, version 5.5).
Results are considered significant when p ≤ 0.05.
RESULTS
There were significant differences between groups [F(2, 43) =
3.30, p < 0.05] and between test conditions [F(1, 43) = 5.49, p <
0.02] in all test parameters except for latencies of entries into
the inner and central areas (p > 0.10), and for the number of
entries into the outer area (p > 0.10). There were, however, sig-
nificant interactions between groups and test conditions only
for the number of entries into the central area [F(2, 43) = 9.37,
p < 0.0004].
The number of entries into the inner and central areas was sig-
nificantly high in presence of an object than in the absence of an
object in all groups (p < 0.02; Figure 1A). However, the duration
of entries into the central area was significantly higher and the
duration of entries into the outer area was significantly lower in
the presence rather than in the absence of an object in all groups
(p < 0.05) (Figure 1B).
In the absence of an object, there were no significant dif-
ferences between groups (p > 0.10; Figure 1). However, in the
presence of an object, mice treated with methimepip crossed sig-
nificantly less into the inner (p < 0.05) and central area (p <
0.0002) and spent less time in the inner area (p < 0.05) compared
to control (Figures 1A,B). There were no significant differences
between the two doses of methimepip (p > 0.10; Figures 1A,B).
EXPERIMENTS 2 AND 3—3D RADIAL MAZE
MATERIALS AND METHODS
Animals
Sixty four male Balb/c and 16 male C57BL/6J mice were pur-
chased from Charles River Laboratories (Kent, UK). The animal
weight was 25–28 g at the time of their arrival. They were housed
four per cage. Individual mice could be identified by their cage
number and their ear tags. They were left to acclimatize for 1 week
before the start of the experiment. The colony room was held and
animals were maintained as described in experiment 1.
Drug treatments
In experiment 2, there were two control groups (C57BL/6J, n = 8
and Balb/c, n = 8) which received physiological saline, and the
other groups (n = 8 each) received a single injection of one dose
each of methimepip (1, 2.5, and 5mg/kg i.p.). In experiment 3,
there were also two control groups (C57BL/6J, n = 8 and Balb/c,
n = 8) which received physiological saline, and three Balb/c
groups (n = 8 each) which received a single injection of one dose
each of JNJ-5207852 (0.5, 1, and 5mg/kg i.p) 30min before intro-
duction to the 3D maze. Methimepip and JNJ-5207852 were kind
gifts from Professor Rob Leurs and Dr. Nicholas Curruthers (JNJ,
USA), respectively. Selection of drug doses was based on previous
in vivo studies (e.g., Kitbunnadaj et al., 2005; Jia et al., 2006).
Apparatus and testing procedure
The 3D maze is a modification of the classic radial-maze
(Ennaceur et al., 2006). It is made from gray PVC (5mm thick)
and consists of eight arms radiating from a central platform. Each
arm (51 × 11.2 cm) is made from two segments, extended from
an octagonal shaped central hub (30 cm in diameter). The first
segment of an arm (15.2 × 11.2 cm) is directly attached to the
central platform and constitutes a bridge that allows access to
the second segment (35 × 11.2 cm). Each bridge can be inde-
pendently tilted upward or downward providing three maze
configurations. In the present study, all bridges were tilted by 40◦
providing a configuration in which the arms are raised horizon-
tal above the level of the central platform. Mice need to climb
onto the bridges and then cross onto the arms. The floor of the
bridges is covered with wire mesh. Sidewalls, about 1 cm high,
extended the length of each bridge and arm. The end of each
arm is extended with panels of identical size (20.2 × 11.2 cm)
which are used to holding cues made of distinctive pattern draw-
ings designed on plastic adhesive material and attached to a PVC
board (18 × 11.2 cm). The maze is totally surrounded with a
FIGURE 1 | Methimepip experiment with rats. Mean (± s.e.m.) in the
open-field with (OBJ) and without object (NOBJ). (A) Number of entries:
∗compared to control in inner area (I), p < 0.05 and ∗compared to control in
central area for both doses of methimepip, p < 0.0002; (B) Duration of
entries: ∗compared to control in the inner area (O) for both doses of
methimepip, p < 0.05.
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heavy beige-light colored curtain. The ambient light at the surface
of the central platform is 180 Lux.
A mouse was removed from its cage, put in a small bucket
in which it was weighted, and then tilted gently on the center
platform of the maze. It was left to explore the test appara-
tus for 12min. The surface of the maze was cleaned to mini-
mize the effects of lingering olfactory cues. Any feces and urine
were removed with paper towels, then cleaned with antibacte-
rial solution followed by 90% ethanol and left to dry before the
introduction of the next mouse.
Tools and recording measures
See similar section in experiment 1.
Measurement and statistical analysis
Differences among group means values for each measurement
were tested for significance with One-Way ANOVA. Anything else
as described in experiment 1.
RESULTS
In both experiments, only C57BL/6J mice (comparator low anx-
iety strain) crossed onto the arms of the maze (not shown).
Their number of crossings onto the bridges (Figures 2B,E) and
duration of entries onto the bridges (Figures 2C,F) was signifi-
cantly higher than in the other groups. Balb/c mice treated with
methimepip (2.5mg/kg i.p.) took significantly longer time to
cross onto the bridges compared to Balb/c mice treated with
saline (p < 0.02) and to Balb/c mice treated with methimepip
at 1 and 5mg/kg i.p. (p < 0.02; Figure 2A). There were no sig-
nificant differences between Balb/c saline treated mice and either
methimepip- or JNJ-5207852-treated mice in any other measures
(Figures 2C–D and F).
DISCUSSION
We demonstrated in previous studies that C57BL/6J mice cross
onto the distal arms of the 3D maze (Ennaceur et al., 2006;
Ennaceur, 2011) and onto the steep hanging slopes of a novel
elevated platform (e.g., Ennaceur et al., 2010; Michalikova et al.,
2010). This demonstrates that these mice are able to take risks
when exposed to unfamiliar open spaces (low anxiety strain).
However, when a shelter is provided in the central platform of
the maze or in the central area of the elevated platform, they
stop crossing onto the arms and slopes, and spend most of the
time inside the shelter. We have also confirmed this with rats
in an enclosed and open space test with and without an object
(Ennaceur et al., 2009a,b). The avoidance or preference responses
observed in the presence of a shelter compare to those observed
in the open-field, the plus-maze and the light/dark box. They
do not provide unequivocal measures of fear-induced anxiety
responses.
In the first experiment, using rats, the number of crossings
into the central area of the open-field was significantly higher
in the presence of an object than in the absence of an object
FIGURE 2 | Methimepip experiment with mice (A–C), JNJ-5207852
experiment with mice (D–F). Mean (± s.e.m.) in the 3D-maze with mice.
(A) Latency: ∗compared to Balb/c saline and methimepip treated mice,
p < 0.05; (B) number of entries, and (E) duration of entries: ∗compared to
Balb/c saline and all methimepip treated mice, p < 0.0002; (C, D, and F) no
significant differences between groups, p > 0.10.
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in agreement with our earlier report (Ennaceur et al., 2009a,b).
This avoidance of the empty central area cannot be attributed to a
state of anxiety in animals. It is accounted for by animals’ pref-
erence for walls and corners that form the open-field and also
by the fact that there is nothing to encourage animals to stop
and explore the central area (see Ennaceur et al., 2009a,b). In
the open-field with an object, methimepip reduced the number
of entries into and time spent in the inner and central areas. This
not due to the effect of the drug on motor or exploratory activity
as this is still higher than in saline and drug treated rats exposed
to the open-field without an object. The presence of an object
seems to further increase this avoidance response. This could
be due to methimepip facilitating or exacerbating fear response
when exposed to novelty. Indeed, it has been suggested that his-
taminergic neurotransmission in the brain is increased in stressful
situations (Dere et al., 2010). In agreement, administration of
histamine H3R agonists has been shown to increase the level of
fear avoidance responses in fear conditioning paradigms (e.g.,
Baldi et al., 2005), in the plus-maze (Pérez-García et al., 1999).
However, in a number of studies histamine H3R antagonists
were also shown to increase the level of fear-induced avoidance
responses in the plus-maze (Pérez-García et al., 1999; Bongers
et al., 2004) and the light/dark box (Imaizumi and Onodera,
1993).
In order to evaluate the role of the H3R in anxiety, we adopted
our recently developed and intensively characterized open space
3D maze test (Ennaceur et al., 2006, 2008; Ennaceur, 2011) with
mice. In this test, animals are exposed to an open-space envi-
ronment where the option to escape/avoid and explore are of
equal valence. We reported that strains of mice display different
levels of anxiety in this test, with Balb/c displaying consistently
higher anxiety than C57BL/6J strains (Ennaceur et al., 2006,
2008; Ennaceur, 2011). Indeed, Balb/c mice alternate between the
central platform and the proximal part of the arms (the bridges)
and only C57BL/6J mice cross onto the distal part of the arms.
In the present study, C57 mice crossed onto the arms of the
maze which is in agreement with our previous findings (Ennaceur
et al., 2006, 2008; Ennaceur, 2011) while all Balb/c treated with
saline, methimepip or JNJ-5207852 did not cross onto the arms.
These results do not suggest any effects of a selective H3 ago-
nist and antagonist on measures of anxiety. This was confirmed
(unpublished) using another selective H3 antagonist/inverse ago-
nist, GSK334429B in a novel elevated platform open space test
(Ennaceur, 2012). The differential effects of H3R modulation on
avoidance and anxiety behaviors may be explained by the growing
anatomical and functional evidence for H3 auto- and hetero-
receptor heterogeneity (Giannoni et al., 2009, 2010; Passani and
Blandina, 2011).
In most studies, the effects of different doses of a drug treat-
ment are compared to saline as control. In experiments 2 and 3,
we included C57BL/6J as a second control group. This is simply
because in order to assess the anxiolytic effect of a drug one would
have to choose the strain of animals with high anxiety and if the
drug produces a reduction in anxiety one would need to demon-
strate that this reduces anxiety below or at least to the level of
low-anxiety strains of animals.
As stated in our introduction, avoidance of the central area or
an object in the central area may be indicative of fear response but
also a preference response of walls and corners. If the definition
of anxiety is based on the conflict between the drive to explore
and the drive to avoid, one must demonstrate evidence in ani-
mals of the drive to explore in this test. In the 3Dmaze, all parts of
the maze are open and unprotected. When released on the central
platform, animals explore the bridges but do not venture further
onto the arms; they alternate between the bridges and the central
platform. The drive to explore is clearly evident by the crossings
onto the bridges.
In previous studies, we demonstrated the difference between
test conditions that promotes fear-induced escape/avoidance and
fear-induced anxiety (Ennaceur et al., 2006; Michalikova et al.,
2010; Ennaceur, 2012). When exposed for the first time to a
3D-maze, C57BL/6J mice venture onto the arms of the maze
while Balb/c mice explore only the central platform and the
bridges. However, if the central platform is enclosed they behave
like Balb/c mice; they do not cross onto the arms of the maze.
Comparable behavior was observed in the elevated platform with
slopes. C57BL/6J mice stop crossing onto the slopes when a hid-
ing place is provided in the middle of the platform (Michalikova
et al., 2010; Ennaceur, 2012). In the presence of a protected space,
animals may not feel the need to take risks away from the pro-
tected space; this is the case in the current unconditioned tests of
anxiety for rats and mice.
In summary, the results of our present experiments with selec-
tive agonist and antagonist drugs provide new evidence that the
H3Rmay have a role in fear-induced avoidance responses, but not
in anxiety.
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